Skip to main content

Table 4 HDL-C (mg/dL) in the 19 patients who completed the study

From: LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia

  Argicolina Normolip Argicolina − Normolip
At start of treatment 56.3 ± 15.6 56.6 ± 16.0 −0.3 (−2.9  +2.3)
At end of treatment 57.7 ± 15.3 59.2 ± 17.1* −1.5 (−3.5  +0.5)
Δ Final–Initial +1.4 (−0.7  +3.5) +2.6 (+0.8  +4.3) −1.2 (−3.8  +1.4)
% Δ(Final–Initial) / Initial +3.0 (−1.3  +7.3) +4.3 (+1.5  +7.1) −1.3 (−6.0  +3.3)
  1. Data are expressed as mean ± SD, (95%CI), and analyzed by Student’s t test for paired data (end vs. start of treatment), * p < 0.01